Healthcare provider profile · identity verified

Daniel Horton, M.D.

Internal Medicine · LYNCHBURG, VA · NPI 1922091701

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	768	229
Rosuvastatin Calcium	Rosuvastatin Calcium	559	164
Amlodipine Besylate	Amlodipine Besylate	512	161
Levothyroxine Sodium	Levothyroxine Sodium	426	118
Metformin Hcl	Metformin Hcl	366	111
Lisinopril	Lisinopril	357	104
Hydrochlorothiazide	Hydrochlorothiazide	336	106
Losartan Potassium	Losartan Potassium	332	102
Simvastatin	Simvastatin	270	76
Omeprazole	Omeprazole	260	84
Pantoprazole Sodium	Pantoprazole Sodium	260	86
Gabapentin	Gabapentin	259	73
Pravastatin Sodium	Pravastatin Sodium	254	71
Allopurinol	Allopurinol	229	56
Tamsulosin Hcl	Tamsulosin Hcl	207	73
Metformin Hcl Er	Metformin Hcl	192	59
Escitalopram Oxalate	Escitalopram Oxalate	179	50
Furosemide	Furosemide	159	48
Eliquis	Apixaban	150	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	149	43
Atenolol	Atenolol	148	42
Metoprolol Tartrate	Metoprolol Tartrate	144	40
Carvedilol	Carvedilol	142	42
Trazodone Hcl	Trazodone Hcl	139	46
Montelukast Sodium	Montelukast Sodium	137	39
Alendronate Sodium	Alendronate Sodium	128	38
Metoprolol Succinate	Metoprolol Succinate	124	42
Bupropion Xl	Bupropion Hcl	118	33
Finasteride	Finasteride	113	37
Sertraline Hcl	Sertraline Hcl	108	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	99	26
Ozempic	Semaglutide	93	23
Prednisone	Prednisone	91	34
Valsartan	Valsartan	89	29
Synthroid	Levothyroxine Sodium	87	22
Diclofenac Sodium	Diclofenac Sodium	86	33
Glimepiride	Glimepiride	85	28
Meloxicam	Meloxicam	85	31
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	84	21
Duloxetine Hcl	Duloxetine Hcl	83	26
Spironolactone	Spironolactone	72	21
Tramadol Hcl	Tramadol Hcl	72	25
Albuterol Sulfate Hfa	Albuterol Sulfate	71	36
Clonazepam	Clonazepam	71	13
Trulicity	Dulaglutide	68	24
Buspirone Hcl	Buspirone Hcl	67	23
Zolpidem Tartrate	Zolpidem Tartrate	67	19
Fluticasone Propionate	Fluticasone Propionate	65	25
Famotidine	Famotidine	64	20
Benazepril Hcl	Benazepril Hcl	63	18
Alprazolam	Alprazolam	60	20
Citalopram Hbr	Citalopram Hydrobromide	58	16
Donepezil Hcl	Donepezil Hcl	56	suppressed
Ezetimibe	Ezetimibe	56	15
Vitamin D2	Ergocalciferol (Vitamin D2)	56	17
Clopidogrel	Clopidogrel Bisulfate	53	17
Xarelto	Rivaroxaban	51	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	49	12
Fluoxetine Hcl	Fluoxetine Hcl	47	suppressed
Ramipril	Ramipril	47	14
Cephalexin	Cephalexin	46	40
Lovastatin	Lovastatin	45	15
Paroxetine Hcl	Paroxetine Hcl	44	14
Venlafaxine Hcl Er	Venlafaxine Hcl	42	13
Pioglitazone Hcl	Pioglitazone Hcl	41	13
Esomeprazole Magnesium	Esomeprazole Magnesium	40	13
Mounjaro	Tirzepatide	40	suppressed
Potassium Chloride	Potassium Chloride	40	15
Triamcinolone Acetonide	Triamcinolone Acetonide	39	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	12
Diazepam	Diazepam	35	suppressed
Jardiance	Empagliflozin	33	11
Meclizine Hcl	Meclizine Hcl	33	17
Nifedipine Er	Nifedipine	33	11
Oxybutynin Chloride Er	Oxybutynin Chloride	33	12
Azithromycin	Azithromycin	32	31
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Chlorthalidone	Chlorthalidone	31	11
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Mirtazapine	Mirtazapine	31	suppressed
Oxycodone Hcl	Oxycodone Hcl	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	12
Warfarin Sodium	Warfarin Sodium	30	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	29	suppressed
Lorazepam	Lorazepam	29	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	24
Doxycycline Hyclate	Doxycycline Hyclate	28	20
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Methylprednisolone	Methylprednisolone	25	18
Pregabalin	Pregabalin	25	suppressed
Torsemide	Torsemide	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	11
Topiramate	Topiramate	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Azelastine Hcl	Azelastine Hcl	23	12
Baclofen	Baclofen	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	17
Januvia	Sitagliptin Phosphate	22	suppressed
Dutasteride	Dutasteride	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Amoxicillin	Amoxicillin	16	13
Calcitriol	Calcitriol	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Primidone	Primidone	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Testosterone	Testosterone	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Trimethoprim	Trimethoprim	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Estradiol	Estradiol	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Risperidone	Risperidone	12	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Nystatin	Nystatin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error